Your Article Summary
See Latest ArticlesLivin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment
Urologic Oncology: Seminars and Original Investigations, 06/29/09
Liu H-B et al. - In a study to evaluate expression of Livin in bladder cancer, investigate its clinical and prognostic implications, and explore the effect of gene Livin transfection on proliferation and apoptosis in bladder cancer cells, it was determined that Livin may serve as a promising marker to identify the relapse risk in bladder cancer, and targeting Livin could offer a therapeutic benefit in apoptosis-inducing treatment.
Methods- Expression of Livin-α and -β was detected in 48 bladder cancer samples (G1 in 23 cases, G2 in 17, and G3 in 8).
- Of the 48 cases, 17 developed relapse and 15 non-tumor bladder tissues by Western blot and reverse transcription PCR (RT-PCR).
- Livin-α-pcDNA3.1(+) was constructed and transfected into T24, BIU-87, and EJ bladder cancer cells.
- Clone activity of the transfected cells was detected by colony formation analysis.
- MTT was used to determine the cell proliferation assay.
- Flow cytometry and acridine orange staining were used to examine apoptosis.
- Caspase 3 activity assay was also measured.
- Expression of Livin-α, but not -β, was detected in 19 of 48 bladder cancer samples; G1 was 39.13%, G2 and G3 were 41.18% and 37.50%, respectively, which showed no significance, but not in 15 non-tumor bladder tissues.
- Positive rate of Livin-α was significantly higher in relapse tumors (58.82%) than in primary tumors (29.03%).
- By 2 yrs follow-up, relapse rate in Livin-positive pts was 68.42%, and 37.93% in Livin-negative group.
- Difference between the 2 groups was significant.
- Overexpression of Livin-α clearly stimulated cell proliferation and inhibited chemical-induced apoptosis in bladder cancer cells.
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Durability of Percutaneous Tibial Nerve Stimulation for the Treatment of Overactive Bladder
The Journal of Urology, 12/16/09
Different Evolution of Voiding Function in Underactive Bladders With and Without Detrusor Overactivity
The Journal of Urology, 12/16/09
Brain Activity Measured by Functional Magnetic Resonance Imaging is Related to Patient Reported Urgency Urinary Incontinence Severity
The Journal of Urology, 12/16/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
The Journal of Urology, 12/16/09
Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study
PLoS Medicine, 12/16/09